新闻BenzingaTwinStrand Biosciences Announces U.S. Patent And Trademark Office's Patent Trial And Appeal Board Rejects Guardant Health's Challenge To Core Patent Underlying Duplex Sequencing TwinStrand Biosciences Announces U.S. Patent And Trademark Office's Patent Trial And Appeal Board Rejects Guardant Health's Challenge To Core Patent Underlying Duplex Sequencing Benzinga 2026.10.15 20:03 (GMT+0) 在Benzinga上打开 其他新闻 布兰迪万房地产信托第三季度FFO为0.14美元，与预期一致；销售额1.25638亿美元，超过预估的1.21617亿美元 美股三大指数集体收涨：SPCX上涨7.64%，Strategy（MSTR）上涨7.62% Anthropic推出主动式AI助手Claude Duet研究预览版 数据：Pump.fun向交易所转入12.98万枚SOL 英国FCA发布两份咨询文件，明确DeFi及加密监管边界 Anthropic最快本周五公开提交IPO申请，估值或达2万亿美元
